Laparoscopy

Insights on Global Medical Robotics Systems Market Size & Share Projected to Hit at USD 38834 Million and Rise at a CAGR of 16.80% By 2028: Industry Trends, Demand, Value, Analysis & Forecast Report | Zion Market Research

Retrieved on: 
Monday, August 8, 2022
Laparoscopy, Pharmacy, Bleeding, Growth, Obstetrics, Hospital, Medical tourism, American College, Patient, Gynaecology, Hysterectomy, Disease, Rancho Los Amigos National Rehabilitation Center, MIS, Solution, Neurosurgery, Efficiency, Adoption, 3D printing, Computer data storage, Medical device

Minimally invasive robotic surgery contributes to these benefits by ensuring higher accuracy and reproducibility, as well as better control and efficiency.

Key Points: 
  • Minimally invasive robotic surgery contributes to these benefits by ensuring higher accuracy and reproducibility, as well as better control and efficiency.
  • On the other hand, procedures using robotic platforms usually show conversion rates of less than 5%, reducing morbidity and blood loss.
  • Global Medical Robotics Systems Market: Opportunities
    Emerging markets and growing medical tourism to bring up growth prospects for the market.
  • Global Medical Robotics Systems Market: Segmentation
    The global medical robotics systems market is segregated on the basis of product & service, application, end-user, end user, and region.

Dr Ivan Puah Recommends Fat Grafting As A Solution Following Post-surgery Scars or Disfigurement

Retrieved on: 
Tuesday, August 2, 2022
Patient, Laser, GLOBE, Research, Hand, Stem cell, Accident, Scar, Disease, Patient satisfaction, Laparoscopy, Review, Touil, Method, Abdomen, Life, Pain, Deformity, Face, Breast, Burns, Dentistry, Petroleum jelly, Hospital, Medical imaging, Medicine

According to Dr Ivan Puah, autologous fat grafting is also highly effective in correcting scars that may occur post-surgery, accidents or even laparoscopy due to its regenerative properties.

Key Points: 
  • According to Dr Ivan Puah, autologous fat grafting is also highly effective in correcting scars that may occur post-surgery, accidents or even laparoscopy due to its regenerative properties.
  • If done properly, scar management with autologous fat grafting can greatly improve the texture and contours of the areas around the scars.
  • Not only does it have functional benefits, fat grafting, according to Dr Ivan Puah, dramatically improves the cosmetic appearance of scars, and this helps patients who suffer from disfigurement due to scars.
  • Dr Ivan Puah believes that autologous fat grafting provides a promising therapeutic potential for treating post-surgery scars and disfigurement.

Olympus Innovation Ventures Backs Endoscopy Video and AI Company, Virgo Surgical Video Solutions

Retrieved on: 
Wednesday, July 27, 2022
Private practice, Investment, Urology, View, Physician, Medicine, HIPAA, Health, Series, Inflammatory bowel disease, SOC, Artificial intelligence, Gastroenterology, HITRUST, Safety, Multimedia, Quality of life, Laparoscopy, Machine learning, Solution, Disease, Endoscopy, Senior, Business development, Patient, Automation, AI, Pharmaceutical industry, Medical device, Medical imaging

CENTER VALLEY, Pa., July 27, 2022 /PRNewswire/ -- Olympus today announced that the company's venture capital fund, Olympus Innovation Ventures, completed its first investment, participating in the Series A financing of Virgo Surgical Video Solutions ("Virgo") of Carlsbad, California.  The Olympus corporate venture capital fund makes investments in emerging digital, device, and diagnostic companies in minimally invasive detection and treatment of disease in gastroenterology, urology, respiratory care and other clinical areas.

Key Points: 
  • CENTER VALLEY, Pa., July 27, 2022 /PRNewswire/ -- Olympus today announced that the company's venture capital fund, Olympus Innovation Ventures, completed its first investment, participating in the Series A financing of Virgo Surgical Video Solutions ("Virgo") of Carlsbad, California.
  • Virgo also leverages endoscopy video data and AI to identify patient candidates for inflammatory bowel disease clinical trials.
  • More information about Olympus Innovation Ventures, which is managed together with Touchdown Ventures , is available at olympusamerica.com/olympus-venture-capital .
  • Virgo Surgical Video Solutions provides the leading cloud video capture, management, and artificial intelligence analysis platform for endoscopic medicine.

New Olympus OEV321UH Monitor Brings Value, Expansion of 4K Offering and a Range of Compatibility Options for Endoscopy and Surgical Suites

Retrieved on: 
Monday, July 25, 2022
ORS, Medicine, Java Advanced Imaging, Small Business Saturday, Multimedia, Backwards, Quality of life, Laparoscopy, Olympus, Endoscopy, Standard of care, Patient, Noise, Observation, Television, Medical device

CENTER VALLEY, Pa., July 25, 2022 /PRNewswire/ -- Olympus announced today the availability of a new monitor option, the OEV321UH video display monitor, a 32-inch Ultra High Definition 4K monitor that expands upon Olympus 4K monitor offerings.

Key Points: 
  • CENTER VALLEY, Pa., July 25, 2022 /PRNewswire/ -- Olympus announced today the availability of a new monitor option, the OEV321UH video display monitor, a 32-inch Ultra High Definition 4K monitor that expands upon Olympus 4K monitor offerings.
  • Backward- and forward-compatible with most Olympus processors, the new monitor provides a breadth of customizable uses at an attractive price point.
  • "With this new OEV321UH Monitor, customers can upgrade their endoscopy suites and ORs to have larger screens that will be important to their practices for a range of cases," said Kevin Mancini, Business Unit Vice President, Endoscopy Division, Olympus America, Inc. "Visualization improvements can translate into meaningful practice improvements that elevate the standard of care."
  • Olympus' Medical portfolio includes endoscopes, laparoscopes, and video imaging systems, as well as surgical energy devices, system integration solutions, medical services, and a wide range of endotherapy instruments.

Outlook on the Medical Robotics Global Market to 2030 - Featuring Medtronic, Omnicell, iRobot and Teladoc Health Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, July 25, 2022
Robotics, Medical Devices, Health, Technology, Surgery, Health Technology, Surgeon, Diabetes, Diagnosis, Arthritis, Environment, Medicine, Conditional sentence, USD, Patient satisfaction, Application, Cancer, CAGR, Laparoscopy, Patient, Pain, Growth, Johns Hopkins University, End user, Nursing, Dentistry, Medical device

The "Medical Robotics Market by Product and Services, by Application, by End-users - Global Opportunity Analysis and Industry Forecast, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Medical Robotics Market by Product and Services, by Application, by End-users - Global Opportunity Analysis and Industry Forecast, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The Medical Robotics Market size was valued at USD 10.88 billion in 2021 and is predicted to reach USD 44.45 billion by 2030 with a CAGR of 17.1% from 2022-2030.
  • Medical robots are professional robots that assist surgeons to perform dexterous surgeries, along with streamlining clinical workflow and hospital logistics.
  • Owing to these advantages, medical robots are widely used in plastic surgery, heart surgery, diagnosis, and out-patient treatment among others.

Georgia Urology returns as sponsor of Volunteer Headquarters at TOUR Championship

Retrieved on: 
Thursday, July 21, 2022
Incontinence, East Lake Foundation, European Championship, Physician, Atlanta metropolitan area, Woman, Proxemic communication strategies, CEO, Infertility, PGA Tour, Pediatrics, Multimedia, Volunteering, Central Volunteer Headquarters, Royal Corps of Signals, Laparoscopy, East Lake Golf Club, Boston Scientific, FedEx, Patient, PGA, Man, Rest, Urology, Tourism

ATLANTA, July 21, 2022 /PRNewswire/ -- Georgia Urology the largest urology practice in Georgia announced today it will return as a sponsor of the TOUR Championship, which will be held August 24-28 at East Lake Golf Club.

Key Points: 
  • ATLANTA, July 21, 2022 /PRNewswire/ -- Georgia Urology the largest urology practice in Georgia announced today it will return as a sponsor of the TOUR Championship, which will be held August 24-28 at East Lake Golf Club.
  • Georgia Urology will partner with Boston Scientific to sponsor the Volunteer Headquarters, the dedicated area where the more than 1,300 volunteers who make the tournament possible can check in and rest, relax, and refresh.
  • "The volunteers of the TOUR Championship serve a great purpose," says Dan Fellner, CEO of Georgia Urology.
  • Georgia Urology is the largest urology practice in Georgia with more than 30 locations and seven ambulatory surgery centers across metro Atlanta.

Worldwide Endoscopy Industry to 2026 - by Product, Application, End-use and Region - ResearchAndMarkets.com

Retrieved on: 
Friday, July 1, 2022
Health, Other Health, Efficiency, Laryngoscopy, Diagnosis, Patient, Conditional sentence, Otoscope, Adoption, Laparoscopy, Endoscopy, R, Growth, Arthroscopy, Industry, Research report, Bladder cancer, Awareness, Cystoscopy, Investment, CAGR, Bronchoscopy, GI, Infection, Mediastinoscopy, Government, Safety, Hematuria, Hospital, Medical device, Medical imaging

In 2021, the flexible endoscopes segment accounted for the largest revenue share with lucrative CAGR during the forecast period.

Key Points: 
  • In 2021, the flexible endoscopes segment accounted for the largest revenue share with lucrative CAGR during the forecast period.
  • Disposable endoscopy segment projected to grow at the fastest CAGR during the forecast period.
  • Based on application, the market is categorized into laparoscopy, gastrointestinal (GI) endoscopy, obstetrics/gynaecology endoscopy, urology endoscopy (cystoscopy), arthroscopy, bronchoscopy, otoscopy, mediastinoscopy, laryngoscopy, and others.
  • The gastrointestinal (GI) endoscopy segment accounted for the highest revenue in 2021 and is projected to maintain its dominance over the forecast period.

Gynecological Devices Market is Predicted to Rise at a CAGR of 3.8% during the Forecast Period, observes TMR Study

Retrieved on: 
Thursday, June 30, 2022
Ageing, Breast pain, Pelvic inflammatory disease, Laparoscopy, Vaginal bleeding, Endoscopy, Endometrial cancer, Cancer, Female, PID, Woman, MIS, Vaginal discharge, Human, CAGR, Top 40, Sexually transmitted infection, Incidence, STD, Ovarian cancer, Birth control

The global gynecological devices market estimated to attain valuation of US$ 25,267.43 Mn by 2027.

Key Points: 
  • The global gynecological devices market estimated to attain valuation of US$ 25,267.43 Mn by 2027.
  • Global gynecological devices market growth is anticipated to be fueled by a rise in the occurrences of gynecological illnesses and a rise in patient demand for less invasive treatments.
  • Additionally, the market is expected to grow as healthcare costs rise, recent developments in the gynecological devices and gynecological illnesses become increasinglyunderstood.
  • Rise in STDs are expected to drive future market demand for gynecological devices in the years to come.

Seattle Reproductive Medicine Launches First Ovarian Tissue Cryopreservation Program in Pacific Northwest

Retrieved on: 
Monday, June 13, 2022
PNW, Woman, Freezing, Life, Time, Infertility, Pacific Northwest, Society, Fertility, IVF, OTC, American Society for Reproductive Medicine, Adolescence, Multimedia, Puberty, Method, Male, Patient, Risk, Laboratory, Sickle cell disease, Reproductive medicine, Laparoscopy, Radiation, SRM, Primary ovarian insufficiency, Menstrual cycle, Fertility preservation, Cryopreservation, Birth control, Medical imaging, Online shopping, Seattle Children's

SEATTLE, June 13, 2022 /PRNewswire/ -- Seattle Reproductive Medicine (SRM) today announced the expansion of its Fertility Preservation Program to include ovarian tissue cryopreservation (OTC), an emerging fertility preservation option for girls and young women undergoing medical treatment that can cause infertility. SRM is the first facility in the Pacific Northwest to provide ovarian tissue processing and freezing in addition to other methods of fertility preservation such as egg and embryo freezing.

Key Points: 
  • SEATTLE, June 13, 2022 /PRNewswire/ -- Seattle Reproductive Medicine (SRM) today announced the expansion of its Fertility Preservation Program to include ovarian tissue cryopreservation (OTC), an emerging fertility preservation option for girls and young women undergoing medical treatment that can cause infertility.
  • "For these patients, ovarian tissue cryopreservation is a vitally important option for preserving their fertility," said Dr. Lynn Davis, who leads SRM's Fertility Preservation Program.
  • Ovarian tissue cryopreservation was considered experimental until 2019, when the American Society for Reproductive Medicine determined that OTC can be regarded as established medical procedure.
  • "We are pleased to be partnering with Seattle Children's to improve access to ovarian tissue cryopreservation for patients who can benefit."

DGAP-News: Moon Surgical Raises $31.3 Million to Accelerate Development of Maestro Robotic System

Retrieved on: 
Tuesday, June 7, 2022
CA, DGAP, Johnson & Johnson, Sofinnova, Partner, News, CEO, Medtech, Solution, Paola Lattus, U.S. Venture Partners, Patient, Technology, Laparoscopy, SAN, Efficiency, Surgeon, Security (finance), Pharmaceutical industry, Dentistry, Maestro

The Series A funding will enable completion of the development of the company's unique co-manipulative surgical robotic product and prepare it for a successful commercial launch.

Key Points: 
  • The Series A funding will enable completion of the development of the company's unique co-manipulative surgical robotic product and prepare it for a successful commercial launch.
  • Moon Surgical will use the funding to expand its team in both France and the United States and accelerate the development of its Maestro Robotic System.
  • "At Moon Surgical, our ambition is to revolutionize minimally invasive surgery through the power of collaborative and adaptive robotics.
  • Our Maestro System can be used in any laparoscopy, in any operating room," said Anne Osdoit, CEO of Moon Surgical, and a Partner in Sofinnova Partners' medtech accelerator, MD Start.